SIGNIFICATO E VALORE DEI MARKERS PREDITTIVI DI EVOLUZIONE IN AIDS AI FINI UNA PRECOCE APPLICAZIONE DELLA TERAPIA CON AZIDOTIMIDINA

M. Moroni(University of Milan), Paul De Cinque(IRCCS Ospedale San Raffaele), Maria Rosa Galli Galli, Aldo Sergio Saracco, Adriano Lazzarin(Vita-Salute San Raffaele University), Antonella Castagna(Vita-Salute San Raffaele University), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University)
Giornale di malattie infettive e parassitarie
January 1, 1989
Cited by 0

Related Papers

Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
|The Lancet|2009|620
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391
Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)
|PLoS Medicine|2013|362
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection
|New England Journal of Medicine|2022|312